Khartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops oral small molecule therapies for immunological and chronic diseases
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Pitching Forge Life Science Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room